Katan Associates is a global strategic consulting firm and corporate finance advisory group focused on Life Sciences. Our mission is to add value to technology based companies, via the implementation of operational and corporate capitalization strategies, that can create and build long-term shareholder value.

Katan strives to consistently deliver results by carefully leveraging our global relationship base to the benefit of our clients. By working with a carefully selected group of clients each year, Katan has the experience to understand the transactional requirements and operational needs that are fundamental to the creation of long-term shareholder value.

News & Events  |  more

• Katan Associates and Biominas Announce Strategic Alliance to Leverage Global Business
• Debiopharm Group and Mercury Therapeutics, Inc. sign an exclusive license agreement
• XL TechGroup arranges new US$25 million borrowing facility